Malformative Reno-Urinary Pathology in Patients with HIV Infection-Clinical and Therapeutic Implications
Autor: | Sotila Gianina Gabriela, Dumitru Magdalena Irina, Rugina Sorin, Dumea Elena, Cernat Roxana |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
hiv infection
medicine.medical_specialty business.industry Urinary system horseshoe kidney antiretroviral therapy 030232 urology & nephrology Human immunodeficiency virus (HIV) virus diseases medicine.disease_cause fanconi syndrome General Biochemistry Genetics and Molecular Biology chronic renal dysfunction 03 medical and health sciences 0302 clinical medicine Internal medicine Medicine In patient 030212 general & internal medicine business |
Zdroj: | ARS Medica Tomitana, Vol 26, Iss 1, Pp 24-30 (2020) |
ISSN: | 1841-4036 |
Popis: | Chronic kidney disease is an important comorbidity of HIV infection causing real problems in the evolution and medical healthcare of HIV-positive patients. In recent years, a significant number of HIV-positive patients develop renal dysfunction, several mechanisms being incriminated: direct effect of the virus, toxic effect secondary to of antiretroviral medication, secondary to associated comorbidities, given that life expectancy has increased significantly in the last decade, thanks to the use of antiretroviral therapies. There are few studies in the literature to evaluate malformative renourinary pathology in patients with HIV infection. We present the case of a patient with HIV infection, horseshoe kidney, chronic kidney disease and incomplete Fanconi syndrome, secondary to the administration of tenofovir fumarate, a nucleoside reverse transcriptase inhibitor. Malformations, abnormalities or dysmorphysms of the renal tract should be considered in the HIV-positive patient with secondary renal dysfunction because they take a wide range of forms, are underdiagnosed and predispose to multiple complications, with varying degrees of severity, such as urinary tract infections, renal stones or progression of chronic kidney disease. Tenofovir fumarate and atazanavir must be avoided in patients with HIV infection and chronic renal dysfunction. |
Databáze: | OpenAIRE |
Externí odkaz: |